<DOC>
	<DOC>NCT01471405</DOC>
	<brief_summary>This non-interventional retrospective study aims to describe the therapeutic procedures and modalities received by patients and the correlation to hormone status, during a one year follow up from completion of the 2-79-52030-207 study.</brief_summary>
	<brief_title>One Year Follow-up of Study 2-79-52030-207 (PRIMARYS) in Acromegalic Patients With Macroadenoma</brief_title>
	<detailed_description />
	<mesh_term>Acromegaly</mesh_term>
	<criteria>Completed the 27952030207 study and received 12 injections of lanreotide Autogel 120 mg, regardless of efficacy at the end of this period. Subject or in case of subject's death next of kin having given their written informed consent prior to collection of the data by the sponsor (if locally required)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>